Rapport Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Rapport Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, to elect directors and ratify auditor appointment.
NASDAQ
DEFA14A: Rapport Therapeutics Sets Date for 2025 Annual Meeting, Outlines Proposals for Stockholder Vote
Rapport Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 17, 2025, with proposals including the election of Class I Directors and ratification of PricewaterhouseCoopers LLP as the independent accounting firm.
NASDAQ
Rapport Therapeutics announces its 2025 annual stockholder meeting to be held virtually on June 17, 2025, to elect directors and ratify the appointment of its independent accounting firm.